ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Repligen Corp Dl 01

Repligen Corp Dl 01 (1RGEN)

0,00
0,00
(0,00%)
Geschlossen 04 Juli 5:30PM

Repligen Corp Dl 01 (1RGEN) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-06-25Mr. Jason K. GarlandCFO & CCO-733,00106,29kAutomatic Disposition145,003,17k-18,78%
2026-05-07Mr. Glenn P. MuirIndependent Director2,43k94,34kDerivative Exercise and Retained Stock38,7638,08k6,83%
2026-05-07Mr. Brian DouglassSenior VP & Chief Product Officer-334,0042,23kSale to Issuer126,431,61k-17,20%
2026-04-21Mr. Olivier LoeillotPresident, CEO & Director-3,83k536,48kVerkauf140,001,00-99,97%
2026-03-04Mr. James R. BylundCOO-62,007,80kSale to Issuer125,8417,67k-0,35%
2026-03-04Mr. Ralf KuriyelSVP of Research & Development-42,005,29kSale to Issuer125,8414,78k-0,28%
2026-02-27Mr. James R. BylundCOO-3,91k494,31kSale to Issuer124,97 - 128,738,28k-32,09%
2026-02-27Mr. Olivier LoeillotPresident, CEO & Director-1,95k245,48kSale to Issuer124,97 - 128,7333,94k-5,44%
2026-03-02Mr. Anthony J. HuntAdvisor-9,90k1,24MSale to Issuer124,9782,49k-10,71%
2026-02-27Mr. Jason K. GarlandCFO & CCO-1,04k131,45kSale to Issuer124,97 - 128,733,90k-21,07%
2026-02-27Mr. Ralf KuriyelSVP of Research & Development-1,37k172,50kSale to Issuer124,97 - 128,7314,70k-8,51%
2026-03-02Mr. Brian DouglassSenior VP & Chief Product Officer-221,0027,62kSale to Issuer124,971,14k-16,21%
2025-12-17Ms. Karen T. DawesLead Independent Director-275,0044,28kVerkauf161,0090,85k-0,30%
2025-12-16Mr. Glenn P. MuirIndependent Director3,37k87,92kDerivative Exercise and Retained Stock26,1235,65k10,43%
2025-12-04Mr. Anthony J. HuntAdvisor-2,00k0,00Other Disposition-79,35k-2,46%
2025-11-25Mr. Olivier LoeillotPresident, CEO & Director-7,04k1,20MVerkauf170,000,00-100,00%
2025-11-18Mr. James R. BylundCOO-2,19k331,30kVerkauf151,216,51k-25,19%
2025-11-13Mr. Anthony J. HuntAdvisor2,95k99,98kDerivative Exercise and Retained Stock33,8764,09k4,83%
2025-11-13Mr. Anthony J. HuntAdvisor-20,00k3,09MVerkauf151,01 - 157,1164,09k-23,79%
2025-11-12Mr. Anthony J. HuntAdvisor-25,00k3,08MDerivative Exercise and Sale33,87 - 158,5181,13k-
2025-10-02Mr. Olivier LoeillotPresident, CEO & Director-1,25k181,25kSale to Issuer145,237,04k-15,06%
2025-09-25Mr. Jason K. GarlandCFO & CCO-412,0050,13kSale to Issuer121,681,95k-17,42%
2025-09-10Mr. Anthony J. HuntAdvisor-20,00k1,72MDerivative Exercise and Sale33,87 - 121,4281,13k-
2025-09-10Mr. Anthony J. HuntAdvisor-9,11k1,11MVerkauf121,42 - 122,2381,13k-10,10%
2025-09-03Mr. Olivier LoeillotPresident, CEO & Director-2,51k291,15kSale to Issuer116,185,71k-30,51%
2025-08-08Dr. Martin D. MadausIndependent Chair of the Board1,80k201,83kKauf112,136,42k38,93%